HBOT and Long Covid

A recent study from the Sagol Hyperbaric Medicine and Research Center in Israel has highlighted the potential of hyperbaric oxygen therapy (HBOT) to promote neuroplasticity and effectively alleviate cognitive, psychiatric, fatigue, sleep, and pain symptoms in patients with post-COVID-19 syndrome.

Research indicates that by enhancing cerebral blood flow and stimulating neuroplasticity in brain regions associated with cognitive and emotional functions, HBOT can significantly improve various symptoms related to post-COVID-19 syndrome. These benefits are observed across cognitive function, mental health, endurance, sleep quality, and pain levels.

post covid 19 syndrome


Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
COVID-19 induced acute respiratory distress syndrome treated with Hyperbaric Oxygen: Interim safety report from a multicenter, randomised, open-label phase II clinical trial (COVID-19-HBO)